-+ 0.00%
-+ 0.00%
-+ 0.00%

AVITA Medical Affirms FY2026 Sales Guidance of $80.000M-$85.000M vs $85.600M Est

Benzinga·02/12/2026 21:06:50
Listen to the news
AVITA Medical (NASDAQ:RCEL) affirms FY2026 sales outlook from $80.000 million-$85.000 million to $80.000 million-$85.000 million vs $85.600 million estimate.